Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand s proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.
Quote | Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Last: | $78.87 |
---|---|
Change Percent: | 0.0% |
Open: | $79.92 |
Close: | $78.87 |
High: | $80.53 |
Low: | $78.295 |
Volume: | 179,843 |
Last Trade Date Time: | 04/17/2024 03:00:00 am |
News | Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
2024-04-16 07:20:23 ET Reporting its Q1 2024 results, Big Pharma’s earnings bellwether, Johnson & Johnson ( NYSE: JNJ ), revised its full-year outlook below consensus on Tuesday after sales from its MedTech division fell short of Street forecasts.... Read the full a...
2024-04-12 23:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)
Subject | By | Source | When |
---|---|---|---|
When next dividends for CVRs? July? January? :-D | S-BEES-BUMBLEBEE | investorshub | 04/26/2023 11:40:10 AM |
any good news ? | Erz | investorshub | 04/25/2023 10:54:07 AM |
You're welcome! | S-BEES-BUMBLEBEE | investorshub | 12/25/2022 11:23:44 AM |
Danke sehr ! | Erz | investorshub | 11/11/2022 8:46:36 AM |
"(..) In connection with our acquisition of Metabasis | S-BEES-BUMBLEBEE | investorshub | 11/10/2022 8:32:13 PM |
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated Company Name:
LGND Stock Symbol:
NASDAQ Market:
2024-04-12 23:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Captisol-enabled™ Topiramate Injection shown to be a substitute for an oral dose on a one-to-one basis Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partners at the University of Minnesota (UMN) and CURx Pharmaceuticals, Inc. presented new data on Ca...
Pharmaceutical executive Scott Plesha named CEO Lead product ZELSUVMI expected to be commercially available in late 2024 Ligand Pharmaceuticals (Nasdaq: LGND) today announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of season...